Perioperative Care Clinical Trial
Official title:
Reducing Surgical Readmissions Through Mobile Technology: A Randomized Controlled Trial
This randomized trial will study the effect of a mobile app that facilitates patient engagement (patients undergoing complex abdominal surgery will track metrics of interest to the surgeon, submit reports on their symptoms/pain/physical function, and upload wound images) on readmission to the hospital. This trial will also assess whether the app can impact surgical complication severity, number of emergency department visits, and readmission costs. 300 participants will be enrolled and can expect to be on study for 6 months.
Hospital readmissions are estimated to cost $17.4 billion per year in the Medicare population alone. Readmission rates may be as high as 30% for patients undergoing complex abdominal surgery. In this study, investigators will conduct a randomized controlled trial (RCT) to assess the effect of a novel mobile technology platform, MobiMD, on hospital readmission in complex abdominal surgery patients. Data from a 50-patient MobiMD pilot study supports the RCT design and mobile platform's feasibility in this study population. Investigators hypothesize that the MobiMD app can facilitate better information transfer between surgeons and patients in the high-risk postoperative time period, thereby reducing hospital readmissions, emergency department visits, complication severity, and overall resource utilization. Investigators will conduct a parallel, single-blinded, 2-arm randomized controlled trial investigating the effect of a novel mobile health app on hospital readmissions for adults undergoing complex abdominal surgery. Three hundred participants (150 patients per arm) will be randomized to compare standard postoperative care alone versus plus MobiMD app. This study is powered to detect a clinically meaningful difference of 11% in readmissions. Participants will be eligible if they undergo any of the following procedures: pancreaticoduodenectomy, cytoreductive surgery/ hyperthermic intraperitoneal chemotherapy (HIPEC), gastrectomy, distal pancreatectomy, liver transplant, pancreas transplant, simultaneous kidney and pancreas transplant, low anterior resection, and any bowel resection requiring an ostomy. The MobiMD app collects important clinical data points and patient-reported outcomes with associated push notifications sent directly to the patient's smart device. Clinical data collected via the MobiMD app include vital signs, red flag symptoms, daily wound and surgical drain images, ostomy output, drain output, medication compliance, and wound care compliance. The primary outcome of the RCT will be 30-day hospital readmission. The secondary outcomes will include 90-day readmission, emergency department and urgent care visits, complication severity, and total readmission cost. Exploratory outcomes will include length of stay and patient-reported outcomes in patient satisfaction, pain, and physical function. All participants will be followed for 6 months. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06043895 -
EpiFaith CV for Central Venous Catheterization
|
N/A | |
Completed |
NCT03308071 -
Hypnosis for Symptom Management in Elective Orthopedic Surgery
|
N/A | |
Not yet recruiting |
NCT03814681 -
Postopoperarive Outcomes After Colorectal Surgery in Europe (euroPOWER)
|
||
Completed |
NCT03012802 -
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol
|
||
Completed |
NCT04724122 -
Perioperative Care in Ethiopia
|
||
Completed |
NCT04037787 -
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Colorectal Cancer Surgery
|
N/A | |
Recruiting |
NCT06101641 -
Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals
|
N/A | |
Not yet recruiting |
NCT03864861 -
Postoperative Outcomes Within an Enhanced Recovery After Bariatric Surgery Protocol
|
||
Not yet recruiting |
NCT03865810 -
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer
|
||
Completed |
NCT00994903 -
Simvastatin in Colorectal Surgery
|
Phase 3 | |
Not yet recruiting |
NCT06436560 -
Support for Transgender and Non-Binary Individuals Seeking Vaginoplasty Study
|
N/A | |
Completed |
NCT00911391 -
Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy
|
Phase 3 | |
Completed |
NCT03325413 -
Improvement of Perioperative Care of Elderly Patients
|
N/A | |
Completed |
NCT04770259 -
Pre-surgical Protocol for Frail Elderly People in Order to Reduce Hospitalization Days (APOPM).
|
N/A | |
Completed |
NCT02580214 -
Immunonutrition in Total Hip Arthroplasty
|
Phase 2/Phase 3 | |
Completed |
NCT01053169 -
Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
|
N/A | |
Completed |
NCT01399814 -
Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
|
Phase 3 | |
Completed |
NCT00464529 -
Accuracy and Safety of Real Time Continuous Glucose Monitoring Before, During and After Surgery
|
N/A | |
Completed |
NCT05352698 -
Validation of B-type Natriuretic Peptide With N-terminal Pro B-type Natriuretic Peptide in Perioperative Risk Assessment
|
||
Completed |
NCT03111875 -
Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery
|
N/A |